newsfilter
← Latest News
GlobeNewswire·

iBio Announces Proposed Public Offering

SAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced it has commenced an underwritten public offering (the "offering") of (i)